Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

Overview of attention for article published in American Heart Journal, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 16 X users

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 20 X posts from 16 X users, with an upper bound of 139,129 followers.

RT @AmericanHeartJ: Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxyma…

Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial https://t.co/f0bIPeA1rg #Cardiology https://t.co/YDgWgnqjWq

RT @IronBiologyBot: Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxyma…

RT @texhern: Getting ready to hear @robmentz present HEART—FID- largest IV iron trial in heart failure What a journey and collaboration a…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 16 additional X posts.